Metallomics for drug development: an integrated CE-ICP-MS and ICP-MS approach reveals the speciation changes for an investigational ruthenium(iii) drug bound to holo-transferrin in simulated cancer cytosol†
Abstract
A method based on combining
* Corresponding authors
a
Vernadsky Institute of Geochemistry and Analytical Chemistry, Russian Academy of Sciences, Kosygin Str. 19, 119991 Moscow, Russian Federation
E-mail:
andrei.timerbaev@univie.ac.at
Fax: +7-495-938-2054
Tel: +7-495-939-7035
b Chair of Analytical Chemistry, Warsaw University of Technology, Noakowskiego 3, 00664 Warsaw, Poland
A method based on combining
Fetching data from CrossRef.
This may take some time to load.
Loading related content